
1 Quantum Computing Stock to Buy Right Now
Rigetti achieved 99.5% 2-qubit gate fidelity, making meaningful progress toward the 99.9% threshold needed for fault-tolerant quantum computing.
With $575 million in cash, Rigetti has the runway to execute its modular scaling approach.
While quantum advantage likely remains two to three years away, Rigetti offers compelling exposure to this transformative technology.
10 stocks we like better than Rigetti Computing ›
The quantum computing revolution has arrived ahead of schedule. What seemed like science fiction just two years ago now powers real computations in research labs and data centers worldwide. The market has taken notice -- quantum computing stocks have delivered strong gains since late 2024.
IonQ, Rigetti Computing (NASDAQ: RGTI), and D-Wave Quantum have all outperformed the S&P 500 (SNPINDEX: ^GSPC) over the past 12 months. The momentum in quantum computing stocks reflects a fundamental shift: Breakthrough innovations have compressed the timeline to commercial quantum advantage from decades to years.
^SPX data by YCharts
Yet not all quantum stocks deserve your investment dollars. After yesterday's groundbreaking announcement, one company has positioned itself as a compelling contender in the race to commercial quantum computing.
When progress is measured in decimal points
Rigetti Computing just achieved what many thought would take years: 99.5% median 2-qubit gate fidelity on its new 36-qubit modular system. This represents a 2x reduction in error rates from Rigetti's previous best -- meaningful progress toward the 99.9% threshold many experts cite as necessary for fault-tolerant quantum computing.
The company demonstrated the industry's largest multichip quantum computer yesterday, built from four 9-qubit chiplets tiled together. This modular architecture matters because it offers a practical path to scaling beyond the fabrication limits that constrain single-chip designs. While Rigetti isn't alone in pursuing modular approaches -- IBM (NYSE: IBM) and others are exploring similar architectures -- the company's execution stands out.
Gate speeds remain a key advantage
Rigetti's superconducting qubits operate orders of magnitude faster than competing technologies like ion traps and neutral atoms. In quantum computing, speed translates to more calculations before quantum states decay -- a critical factor in solving complex problems.
The company plans to launch its 36-qubit system on Aug. 15, with a 100+-qubit, chiplet-based system maintaining that same 99.5% fidelity before 2025 ends. These are ambitious targets in an industry known for delays.
Government contracts signal confidence, not dominance
Rigetti's Q1 2025 results revealed growing government interest in the company's approach. The company secured several research contracts: DARPA's Quantum Benchmarking Initiative worth up to $1 million, Air Force Office of Scientific Research leadership of a $5.48 million consortium, and a 3.5 million pound U.K. Quantum Mission award.
When the Department of Defense and the U.K. government invest millions in your technology, it signals confidence in your approach. These remain R&D contracts rather than full commercial deployments, but they validate Rigetti's technical direction.
Strategic partnerships amplify this validation. Rigetti has partnered with Nvidia on hybrid quantum-classical workflows, suggesting the chip giant sees potential in Rigetti's platform. Quanta Computer closed a $35 million investment in April, bringing manufacturing expertise to the partnership.
The balance sheet provides runway, not immunity
Rigetti completed a $350 million equity offering in June, bringing total cash to approximately $575 million with zero debt. This war chest funds operations without immediate dilution concerns.
Q1 2025 revenue came in at $1.5 million -- minimal for a company at current valuations. While building transformative technology often precedes revenue, investors should monitor cash burn carefully. Operating expenses of $22.1 million quarterly suggest roughly six years of runway at current rates.
The company operates quantum computers over the cloud, sells on-premises systems to national laboratories, and manufactures chips at Fab-1 -- the industry's first dedicated quantum device manufacturing facility. These are real assets, but they're not yet generating meaningful revenue.
The path to quantum advantage remains challenging
Quantum computing represents a generational opportunity comparable to the transistor or the internet. The potential applications -- drug discovery, materials science, cryptography, financial modeling -- could be worth trillions.
Rigetti's modular architecture provides one viable path to scale. By tiling smaller chiplets into larger systems, the company leverages semiconductor industry techniques while working around certain physics constraints. But execution risk remains high, and competitors like IonQ command higher valuations with more commercial traction.
Reality check for quantum investors
Most experts project true quantum advantage -- where quantum computers solve commercially valuable problems faster than classical systems -- arriving between 2026 and 2028. Rigetti's 99.5% fidelity represents real progress, but crossing the final technical hurdles often proves hardest.
For investors willing to accept substantial risk, Rigetti Computing offers exposure to quantum computing's tremendous upside potential. The company has solid technology, adequate funding, and credible partnerships.
But in a field where IonQ, IBM, Alphabet, and several others compete fiercely, picking winners remains a speculative exercise. In other words, position sizing with this name should be paramount right now.
Should you invest $1,000 in Rigetti Computing right now?
Before you buy stock in Rigetti Computing, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Rigetti Computing wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $679,653!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,046,308!*
Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 179% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of July 15, 2025
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
16 minutes ago
- Globe and Mail
Securities Lawsuit Alert: Lockheed Martin Corporation (LMT) Investors - Contact Levi & Korsinsky Before September 26, 2025
New York, New York--(Newsfile Corp. - August 14, 2025) - If you suffered a loss on your Lockheed Martin Corporation (NYSE: LMT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E. Levi, Esq. via email at jlevi@ or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Lockheed Martin Corporation that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between January 23, 2024 and July 21, 2025. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) Lockheed Martin lacked effective internal controls regarding its purportedly risk adjusted contracts including the reporting of its risk adjusted profit booking rate; (2) Lockheed Martin lacked effective procedures to perform reasonably accurate comprehensive reviews of program requirements, technical complexities, schedule, and risks; (3) Lockheed Martin overstated its ability to deliver on its contract commitments in terms of cost, quality and schedule; (4) as a result, the Company was reasonably likely to report significant losses; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. WHAT'S NEXT? If you suffered a loss in Lockheed Martin Corporation stock during the relevant time frame - even if you still hold your shares - go to to learn about your rights to seek a recovery. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

National Post
16 minutes ago
- National Post
Chemtrade Logistics Income Fund to Acquire Polytec, a Provider of Turnkey Water Treatment Solutions
Article content TORONTO — Chemtrade Logistics Income Fund ('Chemtrade' or the 'Fund') (TSX: today announced that it has entered into an agreement to acquire Polytec, Inc. ('Polytec'), a southeastern United States-based provider of turnkey water treatment solutions, for US$150 million. The transaction represents a multiple of approximately 6.5x LTM Adjusted EBITDA. Chemtrade will finance the acquisition by drawing on its credit facility and anticipates it will close during the fourth quarter of 2025, subject to regulatory approvals and customary closing conditions. Following the transaction, Chemtrade expects to maintain ample liquidity and leverage. Article content Polytec was founded over 30 years ago and provides turnkey water treatment solutions to a diverse customer base, primarily in the food-processing industry but also in the municipal market. Article content The purchase of Polytec will add a unique solutions platform to Chemtrade's line of water treatment chemicals products. Chemtrade's North American-wide footprint and internal business systems will be used to leverage Polytec's business, with opportunities for cross-selling in the U.S. and Canada as well as more efficient management of overall business systems. Article content 'This transaction will enable Chemtrade to expand its footprint in water solutions for the food-processing industry and municipal markets while also adding to our range of products,' said Scott Rook, President and CEO of Chemtrade. 'Polytec's founder Jack Harmon has built a company with the reputation of providing the best quality service and products. It is an excellent addition to Chemtrade's capabilities, broad spectrum of customers, logistics network, and technical expertise. Furthermore, the acquisition of Polytec is well-aligned with our strategy of growing the water business and represents an important step towards delivering on the growth pillars of Chemtrade's Vision 2030.' Article content Commenting on the acquisition, Chemtrade's CFO, Rohit Bhardwaj, said 'Our successful leverage reduction strategy has provided Chemtrade with the financial flexibility to pursue compelling growth opportunities such as the acquisition of Polytec while continuing to maintain a conservative balance sheet and leverage within our target range without diluting our unitholders. Our capital deployment decisions remain grounded in financial discipline and are aligned with our goal of driving sustainable earnings growth and attractive total unitholder returns.' Article content Polytec's founder Jack Harmon has committed to staying actively involved in the business in the months following the close of the sale to ensure a smooth transition for employees and customers. Article content 'Polytec was founded over 30 years ago with the commitment to provide customers with high quality service, products, and technology. Over the years, Polytec invested in manufacturing facilities across four Southeastern states with the ability to support customer programs throughout the USA and internationally. The combination of Polytec and Chemtrade will reinforce our manufacturing and service capabilities as we aim to use our knowledge, service, and products to keep our customers compliant with water quality regulations,' said Jack Harmon, founder of Polytec. 'Chemtrade shares a similar vision, and I am confident that the combination of Polytec's unique water treatment solutions and Chemtrade's footprint will further accelerate our growth and the quality service we provide to our customers.' Article content BMO Capital Markets served as financial advisor and Dorsey & Whitney LLP as legal advisor to Chemtrade. Article content About Chemtrade Article content Chemtrade is a Canadian company, headquartered in Toronto, Ontario, which operates a diversified business providing industrial chemicals and services to customers across North America and around the world. Chemtrade is one of North America's largest suppliers of sulphuric acid, spent acid processing services, inorganic coagulants for water treatment, sodium chlorate, sodium nitrite and sodium hydrosulphite. Chemtrade is also a leading producer of high purity sulphuric acid for the semiconductor industry in North America. Chemtrade is a leading regional supplier of sulphur, chlor-alkali products, and zinc oxide. Additionally, Chemtrade provides industrial services such as processing by-products and waste streams. Article content Caution Regarding Forward-Looking Statements Article content Certain statements contained in this news release constitute forward-looking statements within the meaning of certain securities laws, including the Securities Act (Ontario). Forward-looking statements can be generally identified by the use of words such as 'anticipate', 'continue', 'estimate', 'expect', 'expected', 'intend', 'may', 'will', 'project', 'plan', 'should', 'believe' and similar expressions. Specifically, forward-looking statements in this news release include statements with respect to certain future expectations about: Chemtrade's ability to obtain regulatory approvals, to close the acquisition transaction and the timing thereof; the source of funding for the transaction; Chemtrade's ability to maintain ample liquidity and leverage following the transaction; Chemtrade's ability to leverage Polytec's business across North America and via its internal business systems; its ability to cross sell in the US and Canada and to more efficiently manage overall business systems; Chemtrade's ability to expand its water solutions footprint for the food-processing industry and municipal markets while adding to its range of products; and the length of time Mr. Harmon will remain as a consultant. Article content Forward-looking statements in this news release describe the expectations of the Fund and its subsidiaries as of the date hereof. These statements are based on assumptions and involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements for a variety of reasons, including without limitation the risks and uncertainties detailed under the 'RISK FACTORS' section of the Fund's latest Annual Information Form and the 'RISKS AND UNCERTAINTIES' section of the Fund's most recent Management's Discussion & Analysis. Article content Although the Fund believes the expectations reflected in these forward-looking statements and the assumptions upon which they are based are reasonable, no assurance can be given that actual results will be consistent with such forward-looking statements, and they should not be unduly relied upon. Except as required by law, the Fund does not undertake to update or revise any forward-looking statements, whether as a result of new information, future events or for any other reason. The forward-looking statements contained herein are expressly qualified in their entirety by this cautionary statement. Article content Article content Article content Article content Article content


Globe and Mail
16 minutes ago
- Globe and Mail
Levi & Korsinsky Notifies Hims & Hers Health, Inc. (HIMS) Investors - Lead Plaintiff Deadline on August 25, 2025
New York, New York--(Newsfile Corp. - August 14, 2025) - If you suffered a loss on your Hims & Hers Health, Inc. (NYSE: HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E. Levi, Esq. via email at jlevi@ or call (212) 363-7500 to speak to our team of experienced shareholder advocates. Cannot view this video? Visit: THE LAWSUIT: A class action securities lawsuit was filed against Hims & Hers Health, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between April 29, 2025 and June 23, 2025. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) Hims was engaged in the "deceptive promotion and selling of illegitimate, knockoff versions of Wegovy(R) that put patient safety at risk;" (2) as a result, there was a substantial risk that the Company's collaboration with Novo Nordisk would be terminated; and (3) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. WHAT'S NEXT? If you suffered a loss in Hims & Hers Health, Inc. stock during the relevant time frame - even if you still hold your shares - go to to learn about your rights to seek a recovery. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.